Jul 27, 2024, 22:17
A blood test that may predict if people with relapsed MM are going to respond well to CAR-T immunotherapy – Weill Cornell Medicine
Weill Cornell Medicine shared on X:
“A blood test that measures the number of lymphocytes may predict if people with relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new multi-institutional study led by Weill Department of Medicine.
Full story here.”
Source: Weill Cornell Medicine/X